NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF

The present invention relates to a compound of the Formula:or a pharmaceutically acceptable salt thereof.The compound of the present invention inhibits Polθ. This novel therapeutic compound is therefore useful for the treatment and/or prevention of diseases and conditions in which Polθ activity is i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Flanagan, Stuart Robert, Malassis, Julien Gilbert Jacques, Yule, Ian Andrew, Corella, Andrea Guerrero, Hollick, Jonathan, Smith, Matthew Raymond, Bentley, Jonathan Mark
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Flanagan, Stuart Robert
Malassis, Julien Gilbert Jacques
Yule, Ian Andrew
Corella, Andrea Guerrero
Hollick, Jonathan
Smith, Matthew Raymond
Bentley, Jonathan Mark
description The present invention relates to a compound of the Formula:or a pharmaceutically acceptable salt thereof.The compound of the present invention inhibits Polθ. This novel therapeutic compound is therefore useful for the treatment and/or prevention of diseases and conditions in which Polθ activity is implicated, such as, for example but not limited to, the treatment and/or prevention of cancer. The present invention also relates to pharmaceutical compositions comprising the novel therapeutic compound defined herein, to processes for synthesising the compound and to their use for the treatment of diseases and/or conditions in which Polθ activity is implicated.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024336628A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024336628A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024336628A13</originalsourceid><addsrcrecordid>eNrjZLD28w9z9VFw9vcN8A_1cwnWgTCDPUM8_f2APEc_F4UQD9cgxwDX0BBPZ4XQYNdgsICrvxsPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYkPDTYyMDIxNjYzM7JwNDQmThUAnlYqdw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF</title><source>esp@cenet</source><creator>Flanagan, Stuart Robert ; Malassis, Julien Gilbert Jacques ; Yule, Ian Andrew ; Corella, Andrea Guerrero ; Hollick, Jonathan ; Smith, Matthew Raymond ; Bentley, Jonathan Mark</creator><creatorcontrib>Flanagan, Stuart Robert ; Malassis, Julien Gilbert Jacques ; Yule, Ian Andrew ; Corella, Andrea Guerrero ; Hollick, Jonathan ; Smith, Matthew Raymond ; Bentley, Jonathan Mark</creatorcontrib><description>The present invention relates to a compound of the Formula:or a pharmaceutically acceptable salt thereof.The compound of the present invention inhibits Polθ. This novel therapeutic compound is therefore useful for the treatment and/or prevention of diseases and conditions in which Polθ activity is implicated, such as, for example but not limited to, the treatment and/or prevention of cancer. The present invention also relates to pharmaceutical compositions comprising the novel therapeutic compound defined herein, to processes for synthesising the compound and to their use for the treatment of diseases and/or conditions in which Polθ activity is implicated.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241010&amp;DB=EPODOC&amp;CC=US&amp;NR=2024336628A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241010&amp;DB=EPODOC&amp;CC=US&amp;NR=2024336628A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Flanagan, Stuart Robert</creatorcontrib><creatorcontrib>Malassis, Julien Gilbert Jacques</creatorcontrib><creatorcontrib>Yule, Ian Andrew</creatorcontrib><creatorcontrib>Corella, Andrea Guerrero</creatorcontrib><creatorcontrib>Hollick, Jonathan</creatorcontrib><creatorcontrib>Smith, Matthew Raymond</creatorcontrib><creatorcontrib>Bentley, Jonathan Mark</creatorcontrib><title>NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF</title><description>The present invention relates to a compound of the Formula:or a pharmaceutically acceptable salt thereof.The compound of the present invention inhibits Polθ. This novel therapeutic compound is therefore useful for the treatment and/or prevention of diseases and conditions in which Polθ activity is implicated, such as, for example but not limited to, the treatment and/or prevention of cancer. The present invention also relates to pharmaceutical compositions comprising the novel therapeutic compound defined herein, to processes for synthesising the compound and to their use for the treatment of diseases and/or conditions in which Polθ activity is implicated.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLD28w9z9VFw9vcN8A_1cwnWgTCDPUM8_f2APEc_F4UQD9cgxwDX0BBPZ4XQYNdgsICrvxsPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYkPDTYyMDIxNjYzM7JwNDQmThUAnlYqdw</recordid><startdate>20241010</startdate><enddate>20241010</enddate><creator>Flanagan, Stuart Robert</creator><creator>Malassis, Julien Gilbert Jacques</creator><creator>Yule, Ian Andrew</creator><creator>Corella, Andrea Guerrero</creator><creator>Hollick, Jonathan</creator><creator>Smith, Matthew Raymond</creator><creator>Bentley, Jonathan Mark</creator><scope>EVB</scope></search><sort><creationdate>20241010</creationdate><title>NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF</title><author>Flanagan, Stuart Robert ; Malassis, Julien Gilbert Jacques ; Yule, Ian Andrew ; Corella, Andrea Guerrero ; Hollick, Jonathan ; Smith, Matthew Raymond ; Bentley, Jonathan Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024336628A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Flanagan, Stuart Robert</creatorcontrib><creatorcontrib>Malassis, Julien Gilbert Jacques</creatorcontrib><creatorcontrib>Yule, Ian Andrew</creatorcontrib><creatorcontrib>Corella, Andrea Guerrero</creatorcontrib><creatorcontrib>Hollick, Jonathan</creatorcontrib><creatorcontrib>Smith, Matthew Raymond</creatorcontrib><creatorcontrib>Bentley, Jonathan Mark</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Flanagan, Stuart Robert</au><au>Malassis, Julien Gilbert Jacques</au><au>Yule, Ian Andrew</au><au>Corella, Andrea Guerrero</au><au>Hollick, Jonathan</au><au>Smith, Matthew Raymond</au><au>Bentley, Jonathan Mark</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF</title><date>2024-10-10</date><risdate>2024</risdate><abstract>The present invention relates to a compound of the Formula:or a pharmaceutically acceptable salt thereof.The compound of the present invention inhibits Polθ. This novel therapeutic compound is therefore useful for the treatment and/or prevention of diseases and conditions in which Polθ activity is implicated, such as, for example but not limited to, the treatment and/or prevention of cancer. The present invention also relates to pharmaceutical compositions comprising the novel therapeutic compound defined herein, to processes for synthesising the compound and to their use for the treatment of diseases and/or conditions in which Polθ activity is implicated.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2024336628A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title NOVEL COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T09%3A20%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Flanagan,%20Stuart%20Robert&rft.date=2024-10-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024336628A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true